Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
about
Rotavirus vaccines in routine useThe impact of new vaccine introduction on immunization and health systems: a review of the published literatureRotavirus vaccines: current status and future considerationsSystematic review of the economic value of diarrheal vaccinesBurden of acute gastroenteritis, norovirus and rotavirus in a managed care population.Genetic diversity of circulating rotavirus strains in Tanzania prior to the introduction of vaccinationAssociation between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis.Effectiveness of monovalent and pentavalent rotavirus vaccine.Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model.Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines.Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort studyEffectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain.Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalizations and deaths in six Asian countriesPublic Health Impact of Complete and Incomplete Rotavirus Vaccination among Commercially and Medicaid Insured Children in the United States.Estimated hospitalizations attributed to norovirus and rotavirus infection in Canada, 2006-2010.Effectiveness of Rotavirus Vaccination: A systematic review of the first decade of global post-licensure data, 2006-2016.Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study.Group A rotaviruses in children with gastroenteritis in a Canadian pediatric hospital: The prevaccine eraLaboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination.Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United StatesEffectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status.Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA.Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial.Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine.Impact of rotavirus vaccines on rotavirus disease.Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012.Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method.Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.Rotavirus infections in Detroit, USA, a region of low vaccine prevalence.Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.The effectiveness of a rotavirus vaccine in preventing hospitalizations and deaths presumably due to acute infectious diarrhea in Brazilian children: a quasi-experimental study.Treatment and prevention of rotavirus infection in children.Acute gastroenteritis hospitalizations among children aged < 5 years before and after introduction of rotavirus vaccines: a hospital-based surveillance study in Galicia, Spain.Unexpected benefits of rotavirus vaccination in the United States.Rotavirus vaccines: safety, efficacy and public health impact.Prospective study of the burden of rotavirus gastroenteritis in Danish children and their families.The use of an adequate mathematical model is crucial to evaluate vaccine effectiveness.Adoption of rotavirus vaccine by U.S. physicians: progress and challenges.
P2860
Q26853690-75395123-2178-4F73-9839-1141978D533CQ27009450-9FEFCA22-52B2-4BFA-921E-83CD70B55ED0Q27021385-2D2C1266-01E5-40C6-9818-A599C402518CQ33577996-573FD045-B516-4E63-8509-C94D6A927EC6Q33578039-D86109BA-0097-4CE4-9EE1-4AF1779C3164Q33638246-B96A8852-4985-4ED5-B494-229D3A571D28Q33727179-B6EE9CAD-1596-4DB0-8094-3DCE1C765B9AQ33819513-8A17C951-5E05-44C9-85B6-3C1AB5978C12Q33929557-93651FDC-8FE7-4E95-8CD1-87AA7C598F8EQ34064371-80719F6D-7C81-4D90-8125-6EAE4AFCF1B7Q34146235-28E563A1-4F8A-4AF9-8BD8-B83795E94391Q34167722-B66A67C9-BCA2-4309-935E-41900F88B915Q35154120-0A330D8A-9C2D-4A4B-8E20-120BB68FD58EQ35194876-F2669DA2-4931-4934-95D4-9CA9981E082EQ35889946-39C1C561-9BC5-4445-ABD8-8D28F14938BEQ36310196-27F2525C-3776-482F-A627-F1805CB336D2Q36356363-3C094643-4AA1-439A-AA32-C3489E669092Q36573102-E89608E0-9D70-467A-B370-9C92FC750FEFQ36777543-DE987035-6DF0-4B79-9E0D-DC13B7EE84B4Q36851125-10A6859F-8EB8-4094-A790-F1873CB9F3DDQ36978372-2146206F-95FD-4187-A0A1-43AFA6459415Q37375983-C4CEF9DC-5AAB-47F2-B60C-AC12145992DCQ37452293-4325AFEF-19D5-497D-A895-B2A9A13F01C3Q37530043-F62204B7-0518-4626-B687-04FB5E69F504Q37857326-7369CAB6-C490-4C64-B826-3FCC6D35F744Q38018979-FEF89F33-9233-49E4-B9DA-82FF990A6D60Q38176032-BB8D3893-4D95-45FC-B958-B15ED6C3FBC6Q38409090-855A6827-20EC-4B3A-94B3-F04671BFBB47Q38623481-B230831C-0225-456A-B31E-C353BFB40AC3Q39639810-E4214D69-D7C8-40B2-99E2-5F864E49742CQ40393201-0321BEBD-D994-43B8-B94A-94E718A6E325Q40919777-8D1B44D5-4369-4104-86D9-9D4ABBD89D1FQ42269528-63A40A8B-AE18-4001-B53A-B4433BCC5B94Q44179589-D9BDEA39-74FD-4B7C-B3C0-D28FDCE16B80Q44573092-0EC76390-62E8-4271-B305-744B1362D50BQ45165657-1DC00942-D41E-4A19-9EBF-A5D5DD9ADBADQ48690061-A33E9A0E-DAC2-470B-9E0B-224838DA5302Q51338282-2BB9B771-0B1A-4E61-A6CF-6A45799FF1FCQ55381145-AA39049F-ADF7-429B-84AC-E5367A0CEF17
P2860
Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Effectiveness of the pentavale ...... nteritis in the United States.
@en
Effectiveness of the pentavale ...... nteritis in the United States.
@nl
type
label
Effectiveness of the pentavale ...... nteritis in the United States.
@en
Effectiveness of the pentavale ...... nteritis in the United States.
@nl
prefLabel
Effectiveness of the pentavale ...... nteritis in the United States.
@en
Effectiveness of the pentavale ...... nteritis in the United States.
@nl
P2093
P356
P1433
P1476
Effectiveness of the pentavale ...... nteritis in the United States.
@en
P2093
Florence T Wang
Jeanne Loughlin
John D Seeger
Roberta J Glass
T Christopher Mast
P304
P356
10.1542/PEDS.2009-1246
P407
P577
2010-01-25T00:00:00Z